Edwards Lifesciences Corporation Restricted Cash, Current
Edwards Lifesciences Corporation (EW) had Restricted Cash, Current of $2.40 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-04
- 2026-06-30: Restricted Cash, Current $2.40M.
- 2026-03-31: Restricted Cash, Current $1.00M.
- 2025-12-31: Restricted Cash, Current $500.00K.
- 2024-03-31: Restricted Cash, Current $3.60M.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $2.40M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $500.00K 10-Q · filed 2026-08-04 |
| 2024-03-31 | $3.60M 10-Q · filed 2024-04-29 |
| 2023-12-31 | $3.30M 10-Q · filed 2024-04-29 |
| 2023-09-30 | $400.00K 10-Q · filed 2023-10-27 |
| 2023-06-30 | $1.40M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $600.00K 10-Q · filed 2023-04-28 |
| 2022-12-31 | $500.00K 10-K · filed 2024-02-12 |
| 2022-09-30 | $1.10M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $1.80M 10-Q · filed 2022-07-29 |
| 2022-03-31 | $1.30M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $1.50M 10-K · filed 2024-02-12 |
| 2021-09-30 | $9.80M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $12.80M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $16.40M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $16.60M 10-K · filed 2023-02-13 |
| 2019-12-31 | $1.60M 10-K · filed 2022-02-14 |
| 2018-12-31 | $1.50M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |